These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1719 related items for PubMed ID: 12447879
1. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells. Desbois-Mouthon C, Blivet-Van Eggelpoël MJ, Beurel E, Boissan M, Delélo R, Cadoret A, Capeau J. Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879 [Abstract] [Full Text] [Related]
2. Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation. Desbois-Mouthon C, Cadoret A, Blivet-Van Eggelpoël MJ, Bertrand F, Cherqui G, Perret C, Capeau J. Oncogene; 2001 Jan 11; 20(2):252-9. PubMed ID: 11313952 [Abstract] [Full Text] [Related]
3. Endogenous IGF-I protects human intestinal smooth muscle cells from apoptosis by regulation of GSK-3 beta activity. Kuemmerle JF. Am J Physiol Gastrointest Liver Physiol; 2005 Jan 11; 288(1):G101-10. PubMed ID: 15297258 [Abstract] [Full Text] [Related]
4. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer. Liao X, Thrasher JB, Holzbeierlein J, Stanley S, Li B. Endocrinology; 2004 Jun 11; 145(6):2941-9. PubMed ID: 14988390 [Abstract] [Full Text] [Related]
5. Alleviating the suppression of glycogen synthase kinase-3beta by Akt leads to the phosphorylation of cAMP-response element-binding protein and its transactivation in intact cell nuclei. Salas TR, Reddy SA, Clifford JL, Davis RJ, Kikuchi A, Lippman SM, Menter DG. J Biol Chem; 2003 Oct 17; 278(42):41338-46. PubMed ID: 12900420 [Abstract] [Full Text] [Related]
6. Homologous posttranscriptional regulation of insulin-like growth factor-I receptor level via glycogen synthase kinase-3beta and mammalian target of rapamycin in adrenal chromaffin cells: effect on tau phosphorylation. Nemoto T, Satoh S, Maruta T, Kanai T, Yoshikawa N, Miyazaki S, Yanagita T, Wada A. Neuropharmacology; 2010 Jun 17; 58(7):1097-108. PubMed ID: 20144629 [Abstract] [Full Text] [Related]
7. Glycogen-Synthase Kinase3beta/beta-catenin axis promotes angiogenesis through activation of vascular endothelial growth factor signaling in endothelial cells. Skurk C, Maatz H, Rocnik E, Bialik A, Force T, Walsh K. Circ Res; 2005 Feb 18; 96(3):308-18. PubMed ID: 15662032 [Abstract] [Full Text] [Related]
8. The effects of clozapine on the GSK-3-mediated signaling pathway. Kang UG, Seo MS, Roh MS, Kim Y, Yoon SC, Kim YS. FEBS Lett; 2004 Feb 27; 560(1-3):115-9. PubMed ID: 14988008 [Abstract] [Full Text] [Related]
9. The B cell antigen receptor regulates the transcriptional activator beta-catenin via protein kinase C-mediated inhibition of glycogen synthase kinase-3. Christian SL, Sims PV, Gold MR. J Immunol; 2002 Jul 15; 169(2):758-69. PubMed ID: 12097378 [Abstract] [Full Text] [Related]
10. Positive correlation between overexpression of phospho-BAD with phosphorylated Akt at serine 473 but not threonine 308 in colorectal carcinoma. Khor TO, Gul YA, Ithnin H, Seow HF. Cancer Lett; 2004 Jul 16; 210(2):139-50. PubMed ID: 15183529 [Abstract] [Full Text] [Related]
11. Signaling pathways leading to phosphorylation of Akt and GSK-3β by activation of cloned human and rat cerebral D₂and D₃ receptors. Mannoury la Cour C, Salles MJ, Pasteau V, Millan MJ. Mol Pharmacol; 2011 Jan 16; 79(1):91-105. PubMed ID: 20952497 [Abstract] [Full Text] [Related]
12. FTY720 induces apoptosis of human hepatoma cell lines through PI3-K-mediated Akt dephosphorylation. Lee TK, Man K, Ho JW, Sun CK, Ng KT, Wang XH, Wong YC, Ng IO, Xu R, Fan ST. Carcinogenesis; 2004 Dec 16; 25(12):2397-405. PubMed ID: 15297371 [Abstract] [Full Text] [Related]